1Higuchi K,Koizumi W,Tanabe S,et al.Current management ofesophageal squamous-cell carcinoma in Japan and other countries[J].Gastrointest Cancer Res,2009,3(4):153-161.
2Yamamoto S,Ishihara R,Motoori M,et al.Comparison betweendefinitive chemoradiotherapy and esophagectomy in patients withclinical stage I esophageal squamous cell carcinoma[J].Am JGastroenterol,2011,106(6):1048-1054.
3Kato K,Muro K,Minashi K,et al.Phase II Study of Chemoradiotherapywith 5-Fluorouracil and Cisplatin for Stage II-III EsophagealSquamous Cell Carcinoma:JCOG Trial(JCOG 9906)[J].Int JRadiat Oncol Biol Phys,2010,5(1):1-7.
4Ikeda E,Kojima T,Kaneko K,et al.Efficacy of concurrent chemo-radiotherapy as a palliative treatment in stage IVB esophagealcancer patients with dysphagia[J].Jpn J Clin Oncol,2011,41(8):964-972.
5Hurmuzlu M,Monge OR,Smaaland R,et al.High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advancedesophageal cancer:toxicity and outcome[J].Dis Esophagus,2010,23(3):244-252.
6Nishimura Y,Mitsumori M,Hiraoka M,et al.A randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer:Short-term infusion versus protracted infusion chemotherapy(KROSG0101/JROSG021)[J].Radiothe Oncol,2009,9(2):260-265.
9Kubo N,Morimoto J,Sakurai K,et al.Docetaxel with concurrent radiotherapy in patients with inoperable or relapsed oesophageal cancer[J].Gan To Kagaku Ryoho,2010,37(12):2261-2263.
10Li QQ,Liu MZ,Hu YH,et al.Definitive concomitant chemoradio-therapy with docetaxel and cisplatin in squamous esophageal carcinoma[J].Dis Esophagus,2010,23(3):253-259.
6Bidoli P, Slani S, Candis D, et cd. Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagus [J]. Tumori .2001,87(5) :299 - 302.
7Conroy T, Etienne PL, Adenis A, etal. Vinorelbine and eisplatin in metastatic squamous cell carcinoma of the esophagus: response, toxility, quality of life and survival[J] .Ann Oncol,2002,13(5) :721 - 729.
8Cortroy TC, Etiene PL, Adenis A, etal. Phase 11 trial of vinorelbine in metastatic squamous cell esophageal carcinoma[ J]. J Clin Oncol, 1996, 14:64.
9Simoens C, Lardon F. Comparative study of the radiosensitizing and cell cycle effects of vinflunine and vinorelbine, in vitro [J]. BMC Cancer, 2008, 29(8) :5.
8WHO handbook for reporting results of cancer treatment[R].Geneva (Switzerland): World Health Organization Offset Publication No, 197 (9): 48.
9FAKHRIAN K, GAMISCH N, SCHUSTER T, et al. Salvage ra- diotherapy in patients with recurrent esophageal carcinoma [J]. Strahlentherapie und Onkologie, 2012, 188(2): 136-142.
10MOHIUDDIN M, ROSATO F, BARBOT D, et al. Long-term results of combined modality treatment with 1-125 implantation for carcinoma of the pancreas [J]. Int J Radiat Oncol Biol Phys, 1992, 23(2): 305-3111.
